Vitas-M small molecule compound

4-{3-[(5Z)-5-(4-chlorobenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]-2,5-dioxopyrrolidin-1-yl}benzoic acid

Catalog ID
STL005097
SMILES Clc1ccc(cc1)/C=C/1\SC(=S)N(C1=O)C1CC(=O)N(C1=O)c1ccc(cc1)C(=O)O

Contact us by email for worldwide delivery information, pricing, and real‑time availability. Send us your quotation request, and we will confirm stock levels, provide exact costs and lead times, suggest alternatives or find analogs when helpful, and share any additional specifications you may need.

We supply compounds in quantities from 1 mg up to 5 g for research and development purposes only.

We do not supply quantities above 5 g.

Structure and other identifiers

2D representation rendered from the SMILES, with core physicochemical data.
Formula C21H13ClN2O5S2 MW 472.93 g/mol Purity >90% as per NMR
InChI
InChI=1S/C21H13ClN2O5S2/c22-13-5-1-11(2-6-13)9-16-19(27)24(21(30)31-16)15-10-17(25)23(18(15)26)14-7-3-12(4-8-14)20(28)29/h1-9,15H,10H2,(H,28,29)/b16-9-
InChIKey
SRMDTIIGNZBGNS-SXGWCWSVSA-N
Synonyms
573674-08-5
(Z)4(3(5(4chlorobenzylidene)4oxo2thioxothiazolidin3yl)25dioxopyrrolidin1yl)benzoicacid
4(3((5Z)5((4CHLOROPHENYL)METHYLIDENE)4OXO2SULFANYLIDENE13THIAZOLIDIN3YL)25DIOXOPYRROLIDIN1YL)BENZOICACID
4(3((5Z)5(4chlorobenzylidene)4oxo2thioxo13thiazolidin3yl)25dioxopyrrolidin1yl)benzoicacid
4(3(5((4CHLOROPHENYL)METHYLENE)4OXO2THIOXO(13THIAZOLIDIN3YL))25DIOXOAZOLIDINYL)BENZOICACID
4(3(5(1(4CHLOROPHENYL)METH(Z)YLIDENE)4OXO2THIOXOTHIAZOLIDIN3YL)25DIOXOPYRROLIDIN1YL)BENZOICACID
573674085
C1C(C(=O)N(C1=O)C2=CC=C(C=C2)C(=O)O)N3C(=O)C(=CC4=CC=C(C=C4)Cl)SC3=S
Clc1ccc(cc1)C=C1SC(=S)N(C1=O)C1CC(=O)N(C1=O)c1ccc(cc1)C(=O)O
InChI=1SC21H13ClN2O5S2c22135111(2613)91619(27)24(21(30)3116)151017(25)23(18(15)26)147312(4814)20(28)29h1915H10H2(H2829)b169
MFCD03670379
ZINC000002446977
ZINC000020462165

Check stock

See real-time availability and sample size for STL005097 on the Vitas-M platform.

Check stock on Vitas-M

Available files

Download the SDF, MOL, 3D structure and SDS documents from Vitas-M.